Direct factory supply with HPLC/UV batch assay verification, zero-adulteration guarantees, and precision micro-encapsulation formulations for dietary supplements, functional foods, and cosmeceuticals.
As a specialized OEM medicinal plant extract manufacturer based in Xi'an—the heart of China's Qinling Mountains botanical biodiversity corridor—Torzi Biotech operates on a fundamentally different standard than conventional trading intermediaries. Producing high-potency, standardized botanical active compounds requires a rigorous convergence of agricultural chemistry, thermodynamic engineering, and validated analytics.
Our 12,447-square-meter facility implements closed-loop solvent recovery, multi-stage counter-current continuous extraction, vacuum low-temperature falling-film concentration, and macroporous adsorption resin columns to selectively enrich target pharmacophores while eliminating inert ballast, heavy metals, and residual agrochemicals. Every production run is governed by an exhaustive Master Batch Record (MBR), ensuring physical, chemical, and biological consistency across commercial campaigns.
Our extraction lines utilize medical-grade SUS304 and SUS316L stainless steel vessels designed for solvent compatibility, including high-proof grain ethanol, dual-phase hydro-ethanolic extraction, and purified water extractions. Critical thermal parameters are calibrated below 55°C in falling-film evaporators to avoid thermal denaturing of heat-sensitive polysaccharides, polyphenols, and delicate triterpenoids.
Post-concentration, powders are homogenized via dynamic spray-drying towers equipped with HEPA-filtered clean air systems, operating under Class 100,000 cleanroom environments. This prevents ambient microbial contamination and ensures moisture levels consistently below 5.0% for prolonged shelf-life stability.
A critical challenge for nutraceutical formulators is distinguishing between true chemically standardized medicinal plant extracts and non-specific dry ratio extracts. Torzi Biotech applies strict pharmacopoeial methodologies (USP, Ph. Eur., and ChP) to guarantee genuine potency:
| Botanical Matrix | Extraction Profile | Validated Analytical Assay | Primary Bioactive Markers | Industrial Quality Differentiator |
|---|---|---|---|---|
| Reishi (Ganoderma lucidum) | Dual Hydro-Ethanolic Fruiting Body | Megazyme Enzymatic Assay + HPLC | β-1,3/1,6-Glucans ≥25%, Ganoderic Acids ≥4% | Free of starch/maltodextrin adulteration common in mycelium on grain |
| Seabuckthorn (Hippophae rhamnoides) | Supercritical CO2 Fluid Extraction | GC-MS / Fatty Acid Methylation | Palmitoleic Acid (Omega-7) ≥30%, Carotenoids | Completely solventless; zero residual hexane or acetone |
| Black Maca (Lepidium meyenii) | Low-Temp Hydro-Ethanolic Enrichment | HPLC-UV Standardized | Macamides ≥0.6%, Macaenes ≥0.2% | Standardized on true nitrogenous compounds, not generic polysaccharides |
| Celery Seed (Apium graveolens) | Fractionated Solvent Adsorption | TLC & HPLC Fingerprint | 3-n-Butylphthalide (NBP) ≥2.0%, Apigenin | Crisp volatile aromatic retention without oxidized off-flavors |
| Marine Collagen Peptides | Controlled Enzymatic Cleavage | GPC (Gel Permeation Chromatography) | Gly-Pro-Hyp Tripeptides, MW <1,000 Da | Strict molecular weight distribution curve; instantaneous solubility |
Navigating the global botanical ingredients supply chain from 2025 to 2030 requires brand owners and procurement directors to evaluate upstream volatility, regulatory headwinds, and shifts in consumer transparency demands. Based on internal intelligence and international supply contracts across 50+ countries, Torzi Biotech identifies four key macro-trends redefining ingredient sourcing:
Adulteration of medicinal species (such as replacing wild Ginseng or substituting Ganoderma lucidum with inferior fungal matter) has forced FDA and EFSA authorities to demand genetic authentication. Forward-looking buyers now stipulate batch-level DNA barcoding alongside chromatographic fingerprinting.
Global scrutiny on petrochemical residue (Class 1 & 2 solvents under USP <467>) is steering demand toward Subcritical Water Extraction, Supercritical CO2, and pure aqueous systems. Consumer demands for "Clean Label" products mean even traces of ethylene oxide (ETO) or polycyclic aromatic hydrocarbons (PAH4) lead to border rejections.
Enterprise purchasers in the US, EU, and Japan now audit primary cultivation points. Torzi Biotech cultivates long-term GAP (Good Agricultural Practices) contracts across localized mountain belts, maintaining verifiable farmer ledger records, soil pesticide baselines, and sustainable wildcrafting certificates.
Traditional raw extracts suffer from poor intestinal bioavailability and high lipophilicity (e.g., Curcumin, Astaxanthin, CoQ10). Procurement is rapidly shifting toward micro-encapsulated, cold-water-dispersible (CWD), and liposomal botanical formats tailored for ready-to-drink (RTD) beverages and effervescent delivery.
The botanical processing landscape has transitioned from crude decoctions to molecularly targeted phytochemistry. At Torzi Biotech, our engineering roadmap integrates three technological breakthroughs:
Utilizing proprietary protease and cellulase enzyme arrays to gently breakdown stubborn chitinous fungal cell walls and cellulosic plant membranes. This achieves high-yield release of locked active metabolites without employing destructive thermal curves or toxic mineral acids.
Employing multi-stage dynamic resin columns tailored with specific pore diameters and cross-linked polymeric structures. This enables targeted isolation of single bioactive fractions, achieving active monomer purities ranging from 50% to ≥99% (e.g., L-Theanine, Beta-Ecdysterone, Taurine, Sophora japonica derived Quercetin).
To overcome solubility and suspension hurdles in modern beverage production, raw herbal extracts undergo low-temperature micro-pulverization under liquid nitrogen conditions, achieving ultra-uniform D90 < 15 micron particle size distributions without thermal degradation of active volatiles.
When selecting a primary OEM medicinal plant extract partner, contract stability and analytical accountability determine your brand's regulatory compliance. Shaanxi Torzi Biotech Co., Ltd. provides complete end-to-end integration:
Direct answers to core queries raised by supply chain directors, QA managers, and regulatory compliance teams.
Every commercial batch is screened using Thin-Layer Chromatography (TLC) identification against botanical reference standards per USP/ChP monographs. For functional fungi (e.g., Lion's Mane, Reishi), we apply the Megazyme enzymatic assay to measure genuine α-glucan vs β-glucan, actively filtering out maltodextrin, grain carriers, and adulterated starches.
Every lot is delivered with a comprehensive, batch-specific Certificate of Analysis (COA) containing HPLC/UV bioactive potency, moisture, bulk density, mesh particle size, microbiological assays (Total Plate Count, Yeast & Mold, Salmonella, E. Coli), and atomic absorption heavy metal testing. Full Third-Party Lab tests (Eurofins, SGS) are provided upon request.
For catalog standardized botanical extract powders, standard pilot MOQs start at 1 kg to 5 kg to facilitate benchtop formulation and pilot stability testing. For commercial bulk raw ingredients, typical pack sizes are 25 kg fiber drums. For private-label finished capsules or stick-packs, custom OEM programs start from 500 retail units.
We strictly control extraction solvent systems. When organic solvents (such as ethanol) are used, vacuum desolventization ensures that residual solvents strictly comply with ICH and USP <467> guidelines. Additionally, our materials are routinely tested for over 500 pesticide residues, polycyclic aromatic hydrocarbons (PAH4), and are free from ethylene oxide (ETO) irradiation.
Yes. Many lipophilic herbal compounds naturally separate in cold beverages. Utilizing micro-emulsification, natural polysaccharide carriers (such as Acacia gum), and precision agglomeration techniques, we formulate cold-water-dispersible (CWD) powders that yield optically clear, sediment-free solutions suitable for instant drink mixes, ready-to-drink cans, and shots.
Stocked catalog extracts ship within 2 to 5 business days after quality clearance. Custom extraction campaigns, specific mesh milling, or custom compound ratios typically require 10 to 18 business days. Finished turn-key OEM projects (custom capsule filling, blister packaging, secondary labeling) are completed in 3 to 4 weeks, with air and ocean DDP shipping channels worldwide.
Transforming functional botanical actives into consumer-ready shelf units requires reliable processing infrastructure. Torzi Biotech combines raw botanical extraction with advanced finished dosage packaging in pharmaceutical-grade clean environments:
Automated high-speed encapsulators support sizes #00, #0, and #1 in bovine gelatin, vegetarian HPMC, and acid-resistant delayed-release capsules. Custom powder blends, flow-agent optimization, and clean-label silica replacements ensure clean, uniform fills without mechanical jamming.
Double-cone and ribbon blenders ensure high-precision coefficient of variation (CV < 3%) when blending micro-dosed actives with primary superfood bases. We package into nitrogen-flushed single-serve stick packs, multi-serving canisters, or recyclable kraft stand-up pouches.
Navigating global regulatory landscapes is straightforward with our team. We formulate products aligned with US FDA 21 CFR Part 111, Health Canada NHP, and EU Food Supplement Directives, supplying compliant nutrition facts panels, export declarations, and Certificate of Free Sale documents.
Whether you require pilot validation batches from 1 kg or commercial multi-ton production with custom HPLC assay specs, our senior phytochemists and supply team respond within 12 hours with COAs, MSDS, and transparent factory direct pricing.